Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046870	s-ttgabg	— (—)	17455	18973	100.00%	Distribution not available
3046870	s-ttgabg	u/ml (u/ml)	253	294	5.44%
3046870	s-ttgabg	eliau/ml (u/ml)	32	34	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

3872

10603

2.05

315.91

1.1

21.04

3.56

u/ml

1.26

140

Type 1 diabetes, wide definition

1256

3632

3.76

307.65

1.2

1.1

8.88

13.73

u/ml

0.18

Type 1 diabetes

1348

4091

3.55

307.65

1.2

1.1

8.36

13.22

u/ml

0.20

Examination and observation for other reasons

2461

5591

2.65

307.65

1.1

9.01

4.08

u/ml

0.55

Type 1 diabetes, wide definition, subgroup 1

1230

3478

3.86

307.65

1.2

1.1

8.88

14.17

u/ml

0.20

Insulin, fast-acting

1565

5709

2.90

306.81

1.2

1.1

6.63

10.59

u/ml

0.23

Sub-endpoint used in defining T1D endpoints

1355

4496

3.15

305.92

1.2

1.1

7.45

12.71

u/ml

0.24

Autoimmune diseases excluding thyroid diseases, strict definition

3735

10282

2.05

303.54

1.1

21.63

3.62

u/ml

1.26

137

Insulin, fast-acting or short human

1568

5833

2.84

295.81

1.2

1.1

6.63

13.30

u/ml

0.40

Anaemias

1092

2047

3.69

283.14

1.1

7.73

7.19

u/ml

0.02

Pain in joint

2198

5969

2.43

279.39

1.1

8.34

10.04

u/ml

0.08

Autoimmune diseases

3932

10709

1.91

261.17

1.1

16.76

3.56

u/ml

1.21

140

Type 1 diabetes, strict (exclude DM2)

703

1759

4.51

257.26

1.2

1.1

1.55

18.21

u/ml

—

Type 1 diabetes, definitions combined

705

1772

4.49

256.31

1.2

1.1

1.55

18.21

u/ml

—

Depression

3478

12626

1.92

247.95

1.1

14.76

9.15

u/ml

0.26

194

Other diseases of intestines

3771

11656

1.89

246.50

1.1

4.07

14.19

u/ml

1.41

172

Used for control exclusion in common control thyroid runs

3685

9949

1.92

245.79

1.1

17.25

3.87

u/ml

1.01

125

Insulin, intermediate and long-acting

1929

8383

2.32

241.72

1.2

1.1

19.18

10.53

u/ml

0.26

125

Mood disorders, excluding more controls

3300

10422

1.94

237.07

1.1

16.50

6.02

u/ml

0.53

162

Mood disorders

3634

12930

1.87

236.09

1.1

14.56

8.83

u/ml

0.28

202

Mood [affective] disorders

3628

12926

1.87

236.00

1.1

14.56

8.83

u/ml

0.28

202

Insulin, fast-acting (human)

737

2025

3.95

234.09

1.2

1.1

12.41

2.51

u/ml

—

Type 1 diabetes, strict definition

618

1519

4.65

232.65

1.2

1.1

1.64

19.86

u/ml

—

Type 1 diabetes, strict definition, subgroup 1

596

1442

4.74

229.40

1.2

1.1

1.64

21.87

u/ml

—

Irritable bowel syndrome

1207

4482

2.85

229.23

1.1

0.97

7.35

u/ml

0.66

Anxiety (asthma-related co-morbidities)

2353

8959

2.10

220.90

1.1

17.63

6.34

u/ml

0.33

144

All anxiety disorders

2419

9726

2.03

208.19

1.1

17.06

9.97

u/ml

0.19

158

Insulin, combination of fast acting with intermediate-acting or long-acting

2043

9065

2.13

205.01

1.2

1.1

16.45

10.39

u/ml

0.21

127

Constipation

2949

11098

1.89

201.58

1.1

4.17

10.11

u/ml

0.74

160

Anxiety disorders, excluding more controls

2883

10090

1.91

201.10

1.1

9.67

5.79

u/ml

0.20

156

Insulin medication

2043

8386

2.12

199.22

1.2

1.1

16.45

8.15

u/ml

0.31

127

Coeliac disease

691

2051

3.71

197.09

1.3

1.1

57.80

0.99

u/ml

2.27

Other functional intestinal disorders

1620

6784

2.30

196.83

1.1

2.67

11.79

u/ml

1.00

Endocrine, nutritional and metabolic diseases

2893

7822

1.92

193.84

1.1

3.55

12.91

u/ml

0.95

114

Intestinal infectious diseases

3837

12982

1.72

187.91

1.1

15.48

9.13

u/ml

0.29

215

Neurotic, stress-related and somatoform disorders

3146

12500

1.81

187.19

1.1

9.46

8.57

u/ml

0.04

193

Anxiety disorders

3165

12552

1.80

186.79

1.1

9.27

8.54

u/ml

0.03

194

Diseases of oesophagus, stomach and duodenum

3464

11981

1.77

186.60

1.1

6.79

10.19

u/ml

0.26

173

Diverticular disease of intestine

2077

6542

2.08

184.44

1.1

1.16

12.33

u/ml

1.54

100

Other soft tissue disorders, not elsewhere classified

3176

10566

1.80

181.87

1.1

2.94

11.11

u/ml

1.38

160

Pain in limb

2761

10188

1.86

179.04

1.1

2.97

11.28

u/ml

1.29

153

Low back pain

2554

9945

1.89

177.28

1.1

10.60

5.62

u/ml

0.23

147

Abdominal and pelvic pain

3255

9328

1.79

175.98

1.1

10.05

13.20

u/ml

0.14

156

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3210

12874

1.76

175.05

1.1

28.10

5.68

u/ml

1.17

187

Headache

2378

10203

1.91

173.98

1.1

11.65

11.26

u/ml

0.01

146

Symptoms and signs involving the digestive system and abdomen

3244

9334

1.78

171.43

1.1

3.00

13.20

u/ml

1.50

156

Care involving use of rehabilitation procedures

2220

10902

1.93

169.85

1.1

12.10

6.60

u/ml

0.20

160

Other antidepressants

3233

9689

1.74

161.12

1.1

6.67

12.48

u/ml

0.41

142

Recurrent or chronic depression

1458

4704

2.25

160.37

1.1

12.30

6.73

u/ml

0.20

Dorsalgia

3281

10374

1.73

160.29

1.1

10.53

5.49

u/ml

0.26

154

Depression or dysthymia

2155

6199

1.97

158.55

1.1

19.79

6.61

u/ml

0.55

Diarrhoea and gastroenteritis of presumed infectious origin

3323

13208

1.69

157.10

1.1

16.88

9.14

u/ml

0.35

215

Diseases of the digestive system

1494

7145

2.15

156.87

1.2

1.1

40.85

1.17

u/ml

2.22

Gastrointestinal diseases

2063

5293

2.00

155.44

1.1

13.90

1.50

u/ml

0.63

Pure hypercholesterolaemia

2160

7511

1.92

155.09

1.1

12.68

5.22

u/ml

0.32

118

Lower back pain or/and sciatica

3379

13417

1.68

154.44

1.1

8.55

9.16

u/ml

0.03

193

Other specific joint derangements/joint disorders

2588

9451

1.81

154.16

1.1

6.84

16.04

u/ml

0.66

136

Other anxiety disorders

1783

7921

2.02

153.26

1.1

26.21

4.43

u/ml

0.56

124

Metabolic disorders

2935

10464

1.75

153.24

1.1

15.14

5.58

u/ml

0.50

158

Pain in throat and chest

2759

9606

1.76

147.61

1.1

2.38

7.57

u/ml

1.01

149

Depression medications

1100

2229

2.56

146.39

1.1

2.74

6.55

u/ml

0.39

Hypothyroidism (congenital or acquired)

972

2136

2.66

144.14

1.1

17.52

6.91

u/ml

0.31

Hypothyroidism, levothyroxine purchases

965

2121

2.66

143.34

1.1

16.72

6.91

u/ml

0.30

Hypothyroidism and >3 levothyroxin purchases

965

2121

2.66

143.34

1.1

16.72

6.91

u/ml

0.30

Other dorsopathies, not elsewhere classified

3279

10448

1.67

141.96

1.1

8.10

5.49

u/ml

0.16

154

Pain (limb, back, neck, head abdominally)

2257

6187

1.86

139.55

1.1

12.88

10.00

u/ml

0.10

101

Disorders of lipoprotein metabolism and other lipidaemias

2351

8207

1.81

139.35

1.1

12.05

5.63

u/ml

0.29

132

Gastro-oesophageal reflux disease

2076

9969

1.84

137.33

1.1

1.44

7.57

u/ml

1.23

139

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2969

10805

1.69

136.95

1.1

17.00

7.17

u/ml

0.50

175

Personality disorders, excluding more controls

967

4179

2.41

132.76

1.1

1.26

5.17

u/ml

0.69

Tramadol

2411

8545

1.77

131.92

1.1

10.28

6.30

u/ml

0.21

134

General symptoms and signs

3440

10814

1.62

130.76

1.1

7.81

11.07

u/ml

0.20

159

Other headache syndromes

1484

7684

1.99

126.61

1.1

1.24

8.11

u/ml

1.44

104

Asthma

2553

7871

1.74

126.03

1.1

20.86

4.75

u/ml

0.65

131

Soft tissue disorders

3311

10715

1.62

125.83

1.1

6.90

10.93

u/ml

0.30

163

Diabetes, insulin treatment (Kela reimbursement)

3054

11476

1.64

125.53

1.1

16.62

7.13

u/ml

0.49

178

Diabetes medication

3261

12218

1.61

125.25

1.1

18.28

9.87

u/ml

0.36

200

Asthma (mode)

2513

7907

1.74

125.06

1.1

20.85

4.73

u/ml

0.65

132

Diabetes mellitus

3242

11972

1.61

124.27

1.1

11.87

10.03

u/ml

0.08

196

Asthma, excluding more controls

2484

7618

1.74

122.53

1.1

22.37

4.82

u/ml

0.66

126

Other and unspecified anaemias

1217

5654

2.11

121.97

1.1

7.22

8.86

u/ml

0.08

Other anaemias

1223

5700

2.10

120.62

1.1

7.22

8.86

u/ml

0.08

Other intervertebral disc disorders

2444

8727

1.72

120.54

1.1

1.96

5.04

u/ml

0.75

128

Dermatitis and eczema

3448

13874

1.57

118.87

1.1

6.23

11.29

u/ml

0.47

205

Other and unspecified iron deficiency

1107

5319

2.16

116.74

1.1

2.16

5.35

u/ml

0.48

Diabetes, varying definitions

3191

11974

1.59

115.83

1.1

12.20

9.98

u/ml

0.10

197

Aplastic and other anaemias

1298

6147

2.02

115.49

1.1

6.88

12.22

u/ml

0.30

Symptoms and signs involving the circulatory and respiratory systems

3225

10287

1.60

115.46

1.1

13.71

9.96

u/ml

0.18

160

Codeine

2919

9924

1.63

114.49

1.1

2.29

8.81

u/ml

1.22

166

Hypothyroidism, drug reimbursement

527

1218

3.19

114.31

1.1

1.11

10.64

u/ml

—

Any reimbursement code in KELA

2066

5891

1.80

113.27

1.1

15.00

8.04

u/ml

0.24

Any mental disorder

3316

10689

1.58

113.10

1.1

10.32

5.99

u/ml

0.27

165

Intestinal infectious diseases

2963

14387

1.59

113.05

1.1

18.29

8.52

u/ml

0.42

225

Selective serotonin reuptake inhibitors

2988

9855

1.61

111.43

1.1

1.10

14.82

u/ml

2.16

144

Codeine or tramadol medication

3419

12233

1.55

111.06

1.1

2.86

10.85

u/ml

1.54

200

Autoimmune diseases related-to ILD

2614

14020

1.63

110.99

1.1

21.41

7.77

u/ml

0.76

209

Neurological diseases, wide definition

1097

2533

2.23

109.55

1.1

1.02

16.83

u/ml

0.86

Other special examinations and investigations of persons without complaint or reported diagnosis

1959

5619

1.80

108.75

1.1

12.54

4.08

u/ml

0.48

Disease of hard tissues of teeth, NOS

1576

4406

1.91

106.36

1.1

22.51

7.02

u/ml

0.52

Disorders of thyroid, IBD co-morbidities

621

1639

2.76

105.25

1.1

2.97

9.14

u/ml

—

Diseases of liver

1066

5270

2.09

104.29

1.1

4.68

9.60

u/ml

—

Nutritional anaemias

1468

7769

1.87

103.85

1.1

2.09

7.33

u/ml

0.79

111

Exposure to unspecified factor

3083

14587

1.55

103.25

1.1

23.35

7.82

u/ml

0.56

231

Other noninfective gastroenteritis and colitis

900

4211

2.23

102.24

1.2

1.1

6.56

8.41

u/ml

0.09

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1170

2855

2.10

101.24

1.1

0.91

16.19

u/ml

1.02

Medical observation and evaluation for suspected diseases and conditions

1911

5619

1.77

101.20

1.1

15.35

4.08

u/ml

0.64

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3394

12287

1.53

101.17

1.1

4.12

11.87

u/ml

1.16

203

Benign neoplasm of colon, rectum, anus and anal canal

1675

8322

1.79

101.11

1.1

3.19

8.63

u/ml

0.69

128

Symptoms and signs involving cognition, perception, emotional state and behaviour

2873

12709

1.57

101.10

1.1

10.11

7.26

u/ml

0.13

195

Abnormalities of breathing

2759

10245

1.59

100.48

1.1

19.18

9.96

u/ml

0.46

160

Migraine

1808

8593

1.75

99.74

1.1

1.15

14.41

u/ml

1.90

124

Chronic gastritis

803

3622

2.29

99.46

1.1

5.43

1.88

u/ml

0.57

Malaise and fatigue

1534

6904

1.83

98.91

1.1

2.42

9.14

u/ml

0.80

Asthma (only as main-diagnosis)

2232

7871

1.67

98.90

1.1

21.31

4.75

u/ml

0.66

131

Nerve, nerve root and plexus disorders

3053

12301

1.54

98.85

1.1

11.50

8.47

u/ml

0.16

178

Episodal and paroxysmal disorders

3426

11660

1.52

98.76

1.1

6.69

13.71

u/ml

0.49

161

Asthma (only as main-diagnosis), excluding more controls

2195

7618

1.68

98.46

1.1

21.31

4.82

u/ml

0.65

126

Dorsopathies

3173

10619

1.54

98.30

1.1

13.09

7.63

u/ml

0.28

157

Opioids

3003

10170

1.56

97.77

1.1

9.30

8.81

u/ml

0.02

170

Shoulder lesions

2066

7518

1.70

97.42

1.1

2.03

10.04

u/ml

1.21

120

Iron deficiency anaemia

1279

6798

1.91

96.29

1.1

1.91

7.84

u/ml

0.80

Asthma (diagnoses ohter than nonallergic)

2678

14490

1.56

95.36

1.1

19.98

8.34

u/ml

0.45

216

Asthma, unspecified (mode), excluding more controls

1625

6964

1.79

95.32

1.1

20.35

4.93

u/ml

0.43

115

Asthma, including avohilmo

3591

13782

1.49

95.08

1.1

14.68

8.81

u/ml

0.29

203

Symptoms and signs involving the skin and subcutaneous tissue

2126

12976

1.64

94.48

1.1

11.00

5.12

u/ml

0.30

191

Sciatica+with lumbago

1482

7720

1.81

93.77

1.1

12.68

5.44

u/ml

0.29

115

Follow-up examination after treatment for conditions other than malignant neoplasms

1348

4816

1.89

93.56

1.1

1.27

4.42

u/ml

0.96

Asthma, unspecified (mode)

1645

7187

1.76

92.35

1.1

20.35

4.85

u/ml

0.43

120

Chronic rhinitis, nasopharyngitis and pharyngitis

1072

5547

2.00

92.25

1.1

1.95

12.38

u/ml

1.08

Neurological diseases

2722

8825

1.58

92.18

1.1

13.71

13.82

u/ml

0.00

120

Psychiatric diseases

2898

9516

1.55

91.21

1.1

11.16

6.41

u/ml

0.26

142

Noninfective enteritis and colitis

1488

8549

1.78

90.71

1.1

17.43

7.63

u/ml

0.38

112

Behavioural syndromes associated with physiological disturbances and physical factors

2849

13432

1.53

90.54

1.1

17.03

6.84

u/ml

0.46

205

Other and unspecified polyneuropathies, also in other diseases

565

2288

2.58

89.89

1.1

32.64

1.15

u/ml

—

Functional dyspepsia

875

4256

2.13

89.73

1.1

4.60

6.85

u/ml

0.14

Nonorganic sleeping disorders, excluding more controls

682

3008

2.36

89.64

1.1

37.32

1.46

u/ml

—

GASTRO-related operations

2592

8378

1.58

88.26

1.1

15.33

12.41

u/ml

0.11

116

Any gastric operation

2592

8378

1.58

88.26

1.1

15.33

12.41

u/ml

0.11

116

Diseases of the skin and subcutaneous tissue

3012

10079

1.52

87.54

1.1

15.95

9.83

u/ml

0.24

146

Persons encountering health services for specific procedures and health care

3269

13410

1.48

87.27

1.1

18.39

8.64

u/ml

0.44

210

Disorders of adult personality and behaviour

1024

5331

1.99

86.86

1.1

1.30

10.72

u/ml

1.03

Diarrhoea and gastroenteritis of presumed infectious origin

2158

12373

1.60

86.81

1.1

22.60

9.37

u/ml

0.47

188

Statin medication

2007

6927

1.66

85.85

1.1

21.41

6.39

u/ml

0.61

119

Dental caries

706

3077

2.27

85.54

1.1

13.68

9.76

u/ml

—

ILD medications: immunosuppressive drugs

1947

11303

1.63

85.23

1.1

22.02

8.48

u/ml

0.57

167

Hypothyroidism, strict autoimmune

2108

8701

1.62

85.19

1.1

10.27

1.43

u/ml

0.86

112

Other/unspecified dorsalgia

1120

5978

1.91

84.85

1.1

2.64

5.14

u/ml

0.35

Gingivitis and periodontal diseases

2917

10061

1.52

84.56

1.1

12.89

8.84

u/ml

0.15

164

Personality disorders

967

4987

2.01

84.40

1.1

1.26

8.22

u/ml

0.70

Diaphragmatic hernia

1022

5360

1.96

84.30

1.1

1.36

9.15

u/ml

0.89

Sleep disorders (combined)

3338

12088

1.47

83.01

1.1

9.21

7.36

u/ml

0.09

196

Other diseases of hard tissues of teeth

1541

4569

1.78

82.86

1.1

16.79

7.02

u/ml

0.28

Complications of medical and surgical care

2089

12290

1.59

82.44

1.1

20.38

5.38

u/ml

0.63

196

Lumbar disc prolapse

1749

8180

1.67

81.73

1.1

2.00

5.25

u/ml

0.73

120

Disturbances of skin sensation

933

4817

2.00

81.11

1.1

28.14

2.38

u/ml

0.54

Polyneuropathies and other disorders of the peripheral nervous system

624

2770

2.34

80.69

1.1

29.44

7.63

u/ml

—

Persons encountering health services in other circumstances, wide

3429

12299

1.45

80.66

1.1

2.54

11.87

u/ml

1.77

203

Inflammatory bowel disease treatment related agents

3401

13282

1.45

80.51

1.1

22.49

7.31

u/ml

0.77

204

Spondylopathies

2040

7659

1.62

80.28

1.1

11.01

5.38

u/ml

0.28

116

Osteopathies and chondropathies

1625

9186

1.68

80.25

1.1

1.36

9.81

u/ml

1.34

128

Parasetamol

2289

7435

1.58

79.89

1.1

14.12

7.53

u/ml

0.24

106

Polyarthropathies

1927

7853

1.63

79.79

1.1

10.90

15.36

u/ml

0.22

109

Specific personality disorders

854

4306

2.06

79.69

1.1

1.03

9.07

u/ml

0.70

Caries of enamel

2700

13170

1.50

79.45

1.1

6.89

10.12

u/ml

0.23

195

Caries of dentine

625

2709

2.31

79.27

1.1

11.76

12.39

u/ml

—

Diseases of the eye and adnexa

2528

8357

1.54

77.45

1.1

12.04

9.80

u/ml

0.07

131

Sleep disorders

2653

12985

1.50

77.32

1.1

22.36

6.97

u/ml

0.54

199

Asthma-related infections

1751

10716

1.63

77.28

1.1

29.32

9.35

u/ml

0.53

152

Asthma, hospital admission 2, infections

1751

10716

1.63

77.28

1.1

29.32

9.35

u/ml

0.53

152

Benign neoplasm: Colon

1358

7588

1.75

77.02

1.1

3.25

6.98

u/ml

0.44

115

Certain infectious and parasitic diseases

2988

10238

1.48

76.88

1.1

26.70

5.50

u/ml

0.91

159

Persons encountering health services for examination and investigation

1830

5619

1.66

76.75

1.1

14.54

4.08

u/ml

0.40

ILD medications

3377

12901

1.44

75.60

1.1

21.62

7.72

u/ml

0.71

192

Disorders of eyelid, lacrimal system and orbit

2405

12201

1.52

75.57

1.1

10.88

11.23

u/ml

0.01

179

Other arthrosis

1365

5486

1.76

75.34

1.1

1.30

15.26

u/ml

1.54

Symptoms and signs concerning food and fluid intake

402

1509

2.81

75.07

1.1

1.09

23.43

u/ml

—

Insomnia

2610

12941

1.49

74.45

1.1

23.92

6.85

u/ml

0.58

203

Abnormal findings on examination of blood, without diagnosis

1187

6199

1.80

74.05

1.1

25.09

12.38

u/ml

0.32

102

Infections, IBD-co-morbidities

445

1217

2.69

72.98

1.1

66.38

3.93

u/ml

—

Generalized anxiety disorder

626

2908

2.25

72.98

1.1

14.79

3.32

u/ml

—

Other disorders of urethra and urinary system

2044

9575

1.57

72.98

1.1

11.65

10.79

u/ml

0.03

151

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

884

4628

1.96

72.46

1.1

1.19

4.80

u/ml

—

Myalgia

752

3756

2.07

71.76

1.1

1.72

11.29

u/ml

0.81

Disorders of the thyroid gland

2736

12276

1.47

71.70

1.1

8.30

10.39

u/ml

0.14

176

1390

8328

1.69

70.82

1.1

35.97

9.31

u/ml

0.57

115

Diseases of the musculoskeletal system and connective tissue

1739

5387

1.65

70.75

1.1

4.19

11.95

u/ml

0.70

Spondylosis

1341

6478

1.72

70.68

1.1

3.89

5.27

u/ml

0.16

104

Certain infectious and parasitic diseases

2162

7055

1.56

70.19

1.1

15.00

3.00

u/ml

0.48

114

Hypothyroidism, other/unspecified

2601

11732

1.48

70.04

1.1

9.11

8.99

u/ml

0.01

172

Nausea and vomiting

824

4190

1.98

69.94

1.1

2.48

13.53

u/ml

0.77

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1683

10545

1.61

69.67

1.1

27.12

3.72

u/ml

0.78

163

Visual disturbances

1424

8722

1.67

68.84

1.1

40.40

7.10

u/ml

0.64

123

Diseases of pulp and periapical tissues, including avohilmo

3115

11380

1.44

68.81

1.1

2.30

12.31

u/ml

1.77

188

Osteoporosis

754

3567

2.04

68.55

1.1

0.86

1.75

u/ml

1.34

Chronic lower respiratory diseases

3543

13641

1.40

68.23

1.1

22.75

6.15

u/ml

0.92

205

Diseases of oral cavity, salivary glands and jaws

1486

4585

1.69

67.85

1.1

1.16

7.02

u/ml

0.82

Fall on same level

3380

13261

1.41

67.84

1.1

11.39

10.35

u/ml

0.05

206

Hypertension, essential

2084

7739

1.55

67.48

1.1

6.86

3.22

u/ml

0.50

122

Any death

514

7871

0.46

66.97

1.1

2.35

7.66

u/ml

0.74

110

Hypothyreosis and Thyroxine purchase for inclusion criteria

2677

12217

1.46

66.89

1.1

8.81

8.56

u/ml

0.01

182

Falls/tendency to fall

3235

11546

1.42

66.88

1.1

11.67

11.03

u/ml

0.03

188

Other diseases of urinary system

2857

11254

1.45

66.48

1.1

10.01

10.31

u/ml

0.01

174

Other diseases of upper respiratory tract

3155

11714

1.42

65.94

1.1

3.29

8.81

u/ml

0.94

197

Dysphagia

660

3247

2.09

65.46

1.1

7.58

12.17

u/ml

0.21

Complications of surgical and medical care, not elsewhere classified

2740

13179

1.44

65.38

1.1

16.81

7.58

u/ml

0.42

204

Visual disturbances and blindness

1492

9363

1.63

65.13

1.1

38.43

6.90

u/ml

0.64

127

Rotator cuff syndrome

1510

6727

1.64

64.91

1.1

1.89

10.47

u/ml

1.21

112

Other joint disorders

2649

9677

1.46

64.81

1.1

7.03

15.83

u/ml

0.66

138

Collagenous colitis

338

1263

2.84

64.22

1.1

14.58

1.69

u/ml

—

Noninfectious colitis NAS

471

2059

2.39

63.67

1.2

1.1

1.10

2.05

u/ml

—

Hypertensive diseases (excluding secondary)

1558

5640

1.64

63.61

1.1

24.24

4.46

u/ml

0.59

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1554

9908

1.60

63.00

1.1

14.76

5.92

u/ml

0.38

156

ILD medications: prednisolone, methylprednisolone, prednisone

3116

12522

1.41

62.95

1.1

25.04

7.83

u/ml

0.78

189

Dizziness and giddiness

2033

10832

1.51

62.54

1.1

14.92

7.49

u/ml

0.25

170

Phobic anxiety disorders

525

2426

2.26

61.93

1.1

15.08

3.46

u/ml

—

Other systemic involvement of connective tissue (FG)

764

3985

1.95

61.71

1.1

1.51

2.40

u/ml

0.51

Subjective visual disturbances

786

4203

1.93

61.63

1.1

49.88

7.92

u/ml

—

Special screening examination for infectious and parasitic diseases

776

2990

1.96

60.94

1.1

5.82

3.31

u/ml

—

Use of hypnotics and sedatives

2882

11807

1.42

60.87

1.1

1.57

11.31

u/ml

2.00

186

Atopic dermatitis

1852

10090

1.53

60.76

1.1

2.79

14.61

u/ml

1.65

146

Dermatitis

1688

11024

1.55

60.73

1.1

9.52

10.24

u/ml

0.03

160

Complications of procedures, not elsewhere classified

2208

12578

1.47

60.62

1.1

10.45

7.66

u/ml

0.14

196

First line medication for Crohn's disease

3221

12652

1.39

60.35

1.1

23.62

7.80

u/ml

0.75

190

Oral corticosteroids

2939

12518

1.41

60.33

1.1

23.99

5.74

u/ml

0.82

195

Type 2 diabetes, wide definition

2010

8633

1.51

60.05

1.1

16.74

5.28

u/ml

0.46

148

Asthma, hospital admissions , main diagnosis only

2376

14706

1.45

59.48

1.1

19.96

8.12

u/ml

0.46

216

Condition for Implicit Sepsis (Organ dysfunction codes)

2490

12073

1.44

59.14

1.1

12.62

8.19

u/ml

0.20

177

Excluding asthma or asthma-COPD overlap

2313

7943

1.48

59.09

1.1

13.73

4.70

u/ml

0.38

133

Disorders of synovium and tendon

1450

8060

1.60

59.07

1.1

9.58

10.07

u/ml

0.02

123

ILD differential diagnosis

2302

7907

1.48

58.73

1.1

13.73

4.73

u/ml

0.37

132

Cardiac arrhythmias

1750

7455

1.55

58.69

1.1

16.46

7.63

u/ml

0.34

104

Cystitis

2465

10258

1.45

58.60

1.1

10.91

10.29

u/ml

0.02

164

Other pulmonary diagnosis

2309

7943

1.48

58.47

1.1

13.34

4.70

u/ml

0.37

133

Other and unspecified dermatitis

1443

9220

1.60

58.41

1.1

11.05

9.25

u/ml

0.07

129

Disorders of lacrimal system

1200

7321

1.67

58.40

1.1

17.46

7.12

u/ml

0.27

109

COPD differential diagnosis

2300

7910

1.48

58.32

1.1

13.73

4.73

u/ml

0.37

132

Other reaction to severe stress, and adjustment disorders

1138

6872

1.69

58.31

1.1

33.59

4.24

u/ml

0.56

110

Nonorganic sleeping disorders

682

3551

1.99

58.14

1.1

37.32

2.69

u/ml

—

Pain, not elsewhere classified

833

4617

1.85

57.92

1.1

2.74

6.92

u/ml

0.46

Other disorders of lacrimal gland

1004

5882

1.75

57.73

1.1

22.13

8.76

u/ml

0.27

Arthropathies

2704

9737

1.42

57.06

1.1

9.47

15.83

u/ml

0.40

138

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

847

4213

1.85

56.95

1.1

44.36

14.86

u/ml

—

Finngen Rheumatological endpoints

2724

11106

1.41

56.05

1.1

5.99

14.04

u/ml

0.71

166

Chronic sinusitis

1192

7345

1.65

56.01

1.1

51.02

7.80

u/ml

—

125

Cough

1155

6677

1.67

55.85

1.1

14.72

8.13

u/ml

0.22

103

Other symptoms and signs involving cognitive functions and awareness

1128

6232

1.68

55.59

1.1

1.18

4.75

u/ml

0.81

Migraine with aura

853

4833

1.82

55.43

1.1

0.98

6.32

u/ml

1.12

Disorders of conjunctiva

2449

14017

1.42

55.37

1.1

10.57

10.42

u/ml

0.01

213

KRA_PSY_EATING, excluding more controls

368

1535

2.52

55.11

1.1

39.68

1.73

u/ml

—

Other external causes of accidental injury

2367

8274

1.45

55.10

1.1

14.08

8.43

u/ml

0.22

143

Antihypertensive medication - note that there are other indications

2034

7336

1.49

54.96

1.1

24.63

11.55

u/ml

0.42

106

Provisional assignment of new diseases of uncertain etiology

1492

9726

1.56

54.84

1.1

26.82

5.42

u/ml

0.72

137

Hypertension

2110

8182

1.48

54.73

1.1

17.41

3.13

u/ml

0.70

127

Cervicobrachial syndrome

633

3274

1.99

54.71

1.1

0.94

7.48

u/ml

0.84

Symptoms and signs involving the nervous and musculoskeletal systems

1589

10525

1.54

54.50

1.1

2.38

8.29

u/ml

0.98

140

Mycoses

2383

14773

1.42

54.49

1.1

4.59

9.57

u/ml

0.57

230

Codes for special purposes

1492

9743

1.56

54.41

1.1

26.82

5.38

u/ml

0.72

138

Chronic apical periodontitis

3133

13172

1.37

53.91

1.1

4.44

9.47

u/ml

0.69

215

Dental operations

1476

4817

1.60

53.80

1.1

1.22

10.26

u/ml

0.96

Hypertensive diseases

2108

8204

1.47

53.72

1.1

17.41

3.13

u/ml

0.70

127

Acute upper respiratory infections

2918

13161

1.38

53.67

1.1

9.16

6.96

u/ml

0.13

197

Candidiasis

891

5165

1.77

53.46

1.1

0.95

6.82

u/ml

0.66

Injuries to the ankle and foot

2085

12964

1.45

53.33

1.1

11.45

11.39

u/ml

0.00

197

Type 2 diabetes

2598

10899

1.41

53.19

1.1

13.74

6.10

u/ml

0.37

177

Dental pulpitis, including avohilmo

2640

12419

1.40

52.34

1.1

5.80

10.58

u/ml

0.49

195

Somatoform disorder

518

2556

2.10

51.53

1.1

0.90

3.21

u/ml

1.10

Systemic connective tissue disorders

980

5882

1.71

51.52

1.1

1.47

1.97

u/ml

0.38

Spinal stenosis

1130

5271

1.65

51.38

1.1

6.61

4.82

u/ml

0.15

Abnormalities of heart beat

966

5658

1.71

51.25

1.1

1.41

5.28

u/ml

0.70

Conjunctivitis

2258

13476

1.42

50.81

1.1

11.44

9.40

u/ml

0.07

202

Post-traumatic stress disorder

352

1507

2.46

50.39

1.1

7.96

3.18

u/ml

—

Accidents

2332

8274

1.43

50.09

1.1

14.08

8.43

u/ml

0.22

143

Other nutritional deficiencies

1890

12397

1.46

49.93

1.1

9.00

10.11

u/ml

0.05

192

Genitourinary diseases

1622

5370

1.54

49.79

1.1

30.28

15.85

u/ml

0.34

Symptoms and signs involving speech and voice

905

5369

1.73

49.74

1.1

27.01

9.01

u/ml

0.30

Emotionally unstable personality disorder

474

2302

2.15

49.61

1.1

0.99

3.99

u/ml

—

Implicit Sepsis

2151

11142

1.43

49.55

1.1

12.94

8.71

u/ml

0.18

165

Other bacterial intestinal infections

628

3350

1.93

49.50

1.1

2.10

2.55

u/ml

—

Diabetic maculopathy, excluding more controls

319

1311

2.53

49.49

1.2

1.1

20.52

1.23

u/ml

—

Weight loss

337

1430

2.48

49.11

1.1

1.15

1.33

u/ml

—

Dyspnoea

2377

12690

1.40

49.00

1.1

15.48

6.10

u/ml

0.55

184

Voice disturbances

757

4308

1.81

48.47

1.1

32.49

1.75

u/ml

0.46

Oedema, not elsewhere classified

822

4719

1.75

48.17

1.1

1.32

6.44

u/ml

0.73

Second line medication for Crohn's disease

1615

11013

1.49

48.16

1.1

13.25

10.85

u/ml

0.11

152

Other systemic involvement of connective tissue

776

4458

1.79

48.03

1.1

1.51

2.20

u/ml

0.45

Soft tissue disorders related to use, overuse and pressure

691

3834

1.85

47.91

1.1

1.00

11.15

u/ml

0.97

Benzodiazepine use

2721

13857

1.37

47.84

1.1

8.27

9.24

u/ml

0.05

219

Covid-19 confirmed case

955

5802

1.68

47.80

1.1

50.76

5.61

u/ml

0.72

Irregular menses

1583

8466

1.51

47.65

1.1

15.83

5.42

u/ml

0.62

136

Other arrhythmias

1748

9078

1.47

47.54

1.1

13.35

6.16

u/ml

0.26

124

Other disorders of skin and subcutaneous tissue

1770

10905

1.46

47.45

1.1

18.40

3.05

u/ml

0.67

163

3166

12301

1.34

47.35

1.1

8.17

7.33

u/ml

0.05

179

Cardiovascular diseases

2004

7533

1.45

47.20

1.1

32.42

8.08

u/ml

0.81

Factors influencing health status and contact with health services

748

2049

1.86

46.99

1.1

0.81

5.91

u/ml

—

Abnormal serum enzyme levels

644

3429

1.87

46.65

1.1

35.43

13.75

u/ml

—

Bipolar affective disorders

580

3080

1.94

46.55

1.1

0.87

1.66

u/ml

—

Migraine without aura

714

4049

1.82

46.49

1.1

1.21

15.51

u/ml

—

Pain in thoracic spine

460

2256

2.11

46.48

1.1

1.04

3.52

u/ml

—

Diseases of pulp and periapical tissues and dental caries

1689

5859

1.50

46.19

1.1

1.89

10.94

u/ml

1.18

102

External causes of morbidity and mortality

1937

6748

1.46

46.15

1.1

4.28

8.23

u/ml

0.52

120

Persons encountering health services for specific procedures, not carried out

299

1238

2.54

46.00

1.1

6.90

3.52

u/ml

—

Persistent mood disorders

559

2945

1.95

45.92

1.1

1.28

1.71

u/ml

—

Asthma/COPD (KELA code 203)

2672

13604

1.36

45.86

1.1

12.14

6.15

u/ml

0.26

205

Pain and other conditions associated with female genital organs and menstrual cycle

715

3729

1.82

45.83

1.1

2.09

11.36

u/ml

—

Implicit viral Sepsis

767

4447

1.76

45.76

1.1

37.50

6.45

u/ml

—

Unspecified mental disorder

1132

7265

1.59

45.13

1.1

1.34

7.95

u/ml

1.02

104

Other retinal disorders

1516

7995

1.50

45.11

1.1

6.44

7.27

u/ml

0.05

127

L04AX Other immunosuppressants

1551

10638

1.48

44.94

1.1

12.74

11.40

u/ml

0.06

146

Other gastritis (incl. Duodenitis)

562

2987

1.93

44.78

1.1

5.98

9.61

u/ml

—

Reimbursement for rheumatic diseases

1548

10602

1.48

44.22

1.1

7.84

9.43

u/ml

0.08

147

Allergic asthma (mode), excluding more controls

759

4339

1.75

44.07

1.2

1.1

23.95

6.70

u/ml

0.35

Dental caries, including avohilmo

1859

6624

1.45

43.99

1.1

1.72

10.98

u/ml

1.38

113

Other specified/unspecified arthritis

732

4239

1.77

43.94

1.1

0.93

12.63

u/ml

1.06

Condition for Implicit Sepsis (Organ dysfunction codes)

2234

11471

1.39

43.91

1.1

12.34

8.48

u/ml

0.17

170

Implicit Sepsis

1896

10142

1.43

43.80

1.1

14.36

8.51

u/ml

0.23

152

Allergic asthma (mode)

759

4357

1.75

43.45

1.2

1.1

23.95

6.70

u/ml

0.35

Other diseases of lip and oral mucosa

1090

7004

1.59

43.40

1.1

1.10

7.77

u/ml

1.04

104

Caries of dentine, including avohilmo

2045

7432

1.42

43.16

1.1

2.28

12.82

u/ml

1.47

125

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

949

5861

1.64

42.78

1.1

10.71

13.43

u/ml

—

Dentofacial anomalies [including malocclusion]

2049

11912

1.40

42.63

1.1

9.44

8.84

u/ml

0.02

172

Schizophrenia or delusion, excluding more controls

783

4605

1.72

42.62

1.1

1.16

5.59

u/ml

0.69

COPD/asthma related infections

2920

11033

1.34

42.53

1.1

9.20

6.71

u/ml

0.15

163

COPD/asthma/ILD related infections

2920

11033

1.34

42.53

1.1

9.20

6.71

u/ml

0.15

163

Disorders of choroid and retina

1928

9781

1.42

42.48

1.1

5.91

7.86

u/ml

0.14

160

Disorders of other endocrine glands

1261

8279

1.53

41.99

1.1

1.59

12.54

u/ml

1.46

111

Missing teeth due to accident, extraction or parodontitis

1409

9065

1.49

41.40

1.1

1.04

6.64

u/ml

1.28

144

Heartburn

318

1416

2.33

41.18

1.1

0.92

3.38

u/ml

—

Other arthritis (FG)

827

5042

1.67

40.96

1.1

0.98

10.49

u/ml

1.06

Obesity related asthma

897

5594

1.64

40.59

1.1

21.41

5.52

u/ml

0.34

Haemorrhoids and perianal venous thrombosis

735

4350

1.72

40.24

1.1

2.49

11.05

u/ml

0.77

Viral and other specified intestinal infections

903

5451

1.63

40.19

1.1

0.96

10.70

u/ml

—

Temporomandibular joint disorders, including avohilmo

1360

9216

1.48

39.23

1.1

16.57

7.63

u/ml

0.24

140

Disorders of skin appendages

1371

9437

1.48

38.98

1.1

16.64

10.19

u/ml

0.26

142

Benign neoplasms

2656

11068

1.34

38.91

1.1

18.37

8.88

u/ml

0.43

160

Non-selective monoamine reuptake inhibitors

907

5520

1.61

38.57

1.1

1.15

9.20

u/ml

0.90

Carpal tunnel syndrome

1531

9472

1.44

38.54

1.1

14.87

6.76

u/ml

0.38

141

Cervical disc disorders

830

5142

1.64

38.42

1.1

24.20

5.22

u/ml

0.36

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1293

8574

1.49

38.27

1.1

1.20

8.98

u/ml

1.56

144

Hypothyroidism, strict autoimmune, 3 medication purchases required

2293

11555

1.36

38.23

1.1

9.55

9.15

u/ml

0.02

168

Acute upper respiratory infections of multiple and unspecified sites

2072

11310

1.37

38.16

1.1

24.79

7.71

u/ml

0.55

164

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

884

5591

1.62

37.90

1.1

1.19

9.79

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

1976

8271

1.39

37.63

1.1

20.64

11.39

u/ml

0.35

108

Substance abuse, excluding more controls

1293

7517

1.48

37.62

1.1

21.82

7.02

u/ml

0.45

110

Obesity, other/unspecified

972

6304

1.57

37.26

1.1

1.82

10.93

u/ml

1.15

Excessive, frequent and irregular menstruation

1241

4552

1.52

37.06

1.1

15.65

9.34

u/ml

0.24

Disorders of gallbladder, biliary tract and pancreas

2473

11794

1.34

37.05

1.1

8.61

7.49

u/ml

0.06

177

Haemorrhage from respiratory passages

777

4297

1.66

36.83

1.1

2.14

11.22

u/ml

0.87

Obsessive-compulsive disorder

270

1184

2.40

36.76

1.1

1.38

3.83

u/ml

—

Asthma-related pneumonia

887

5641

1.60

36.55

1.1

35.49

9.22

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

233

648

2.61

36.52

1.1

0.88

6.22

u/ml

—

Rheumatoid arthritis

784

4336

1.65

36.46

1.1

15.14

10.94

u/ml

0.10

All kidney diseases

2650

13896

1.32

36.36

1.1

18.45

9.10

u/ml

0.44

209

Asthma, hospital admissions 3, pneumonia

888

5660

1.59

36.24

1.1

35.49

9.12

u/ml

—

Asthma-related pneumonia or sepsis

888

5660

1.59

36.24

1.1

35.49

9.12

u/ml

—

Need for other prophylactic measures

210

829

2.68

36.08

1.1

—

1.75

—

Bronchitis

2894

14137

1.30

36.07

1.1

17.34

6.76

u/ml

0.50

212

Mixed and other personality disorders

273

1212

2.36

35.99

1.1

1.90

0.86

u/ml

—

Other enthesopathies

739

4533

1.66

35.75

1.1

1.31

11.35

u/ml

1.12

Cervicalgia

532

2992

1.82

35.50

1.1

1.38

7.40

u/ml

—

Other heart diseases, wide

2527

11807

1.32

35.15

1.1

19.97

7.45

u/ml

0.70

161

Trochanteric bursitis

391

2004

2.01

35.08

1.1

0.85

2.21

u/ml

—

Sleep apnoea, including avohilmo

2494

11793

1.32

34.91

1.1

10.31

6.08

u/ml

0.19

182

Deforming dorsopathies

746

4618

1.65

34.90

1.1

14.29

6.54

u/ml

0.32

Periodontitis

2390

12160

1.33

34.76

1.1

2.85

8.35

u/ml

1.14

193

Fever of other and unknown origin

1399

8766

1.44

34.69

1.1

12.92

12.09

u/ml

0.03

122

Asthma and allergy

460

2466

1.90

34.59

1.2

1.1

1.13

1.94

u/ml

—

Asthma and allergy, excluding more controls

461

2480

1.89

34.29

1.2

1.1

1.13

1.96

u/ml

—

Chronic diseases of tonsils and adenoids

2199

10464

1.34

34.22

1.1

10.11

10.32

u/ml

0.01

164

Chronic periodontitis, including avohilmo

2379

12155

1.32

34.13

1.1

2.85

8.35

u/ml

1.14

193

Poisoning by drugs, medicaments and biological substances

707

4350

1.66

34.08

1.1

1.22

8.60

u/ml

—

Exposure to other specified factors

2021

13932

1.35

33.84

1.1

2.62

12.03

u/ml

1.89

218

Atopic dermatitis, strict definition with reimbursement

962

6139

1.54

33.77

1.1

1.10

13.87

u/ml

1.38

Other diseases of anus and rectum

672

4078

1.67

33.57

1.1

1.11

10.91

u/ml

0.96

Diseases of the respiratory system

1803

6569

1.39

33.55

1.1

3.61

5.15

u/ml

0.20

112

Infections of the skin and subcutaneous tissue

1522

10870

1.41

33.44

1.1

15.04

10.24

u/ml

0.20

154

Thyroiditis, ILD-related definition

375

1937

2.01

33.16

1.2

1.1

9.68

2.00

u/ml

—

2384

11026

1.32

33.16

1.1

19.67

6.71

u/ml

0.52

163

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2384

11026

1.32

33.16

1.1

19.67

6.71

u/ml

0.52

163

Viral infections characterized by skin and mucous membrane lesions

2306

15106

1.32

33.11

1.1

22.96

8.67

u/ml

0.47

236

Excessive attrition of teeth

1527

11051

1.40

33.02

1.1

0.99

12.35

u/ml

2.09

162

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1512

9755

1.40

32.72

1.1

9.52

7.98

u/ml

0.08

147

Concussion

1323

7593

1.44

32.63

1.1

2.21

10.31

u/ml

1.01

Diseases of the ear and mastoid process

3173

12596

1.28

32.59

1.1

14.08

7.77

u/ml

0.35

177

General examination and investigation of persons without complaint and reported diagnosis

1515

5615

1.42

32.51

1.1

11.19

4.08

u/ml

0.40

Papulosquamous disorders

973

6506

1.52

32.33

1.1

19.24

8.29

u/ml

0.39

Rheumatism, unspecified

384

2014

1.97

32.28

1.1

1.51

2.22

u/ml

—

Adhesive capsulitis of shoulder

404

2151

1.93

32.25

1.1

1.12

9.15

u/ml

—

Syncope and collapse

1072

6226

1.49

32.23

1.1

1.85

6.08

u/ml

0.76

Hernia

2328

11974

1.32

31.85

1.1

1.45

8.58

u/ml

1.81

186

Necrosis of pulp, including avohilmo

1506

10905

1.40

31.85

1.1

16.44

8.84

u/ml

0.35

161

Eating disorder

374

1967

1.99

31.53

1.1

39.68

5.02

u/ml

—

L04AA Selective immunosuppressants

620

3767

1.69

31.50

1.1

60.15

2.57

u/ml

0.97

Convulsions, not elsewhere classified

632

3802

1.67

31.46

1.1

1.29

19.85

u/ml

1.00

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1579

11250

1.38

31.45

1.1

1.18

8.86

u/ml

1.61

177

Postprocedural endocrine and metabolic disorders, not elsewhere classified

374

1964

1.97

31.42

1.1

1.18

2.33

u/ml

—

Ovarian cyst

1074

4178

1.51

31.36

1.1

1.52

9.46

u/ml

0.62

Poisoning by medicine

641

3932

1.67

31.35

1.1

1.22

9.73

u/ml

—

Atopic dermatitis, strict definition

953

6261

1.52

31.34

1.1

1.10

14.86

u/ml

1.41

Coxibs

695

2217

1.68

31.25

1.1

0.91

5.89

u/ml

—

Budesonide

402

2163

1.91

31.25

1.1

7.98

1.80

u/ml

—

Migraine with aura and triptan purchases

536

3147

1.76

31.20

1.1

1.24

8.94

u/ml

—

Obesity

1683

12033

1.37

31.16

1.1

1.47

11.75

u/ml

2.02

179

Arthrosis

1625

6471

1.39

31.12

1.1

1.06

13.81

u/ml

1.72

Obesity and other hyperalimentation

1688

12063

1.37

31.05

1.1

1.47

11.70

u/ml

2.02

180

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

920

6140

1.53

31.01

1.1

1.14

5.59

u/ml

0.68

Other bacterial diseases

2617

12978

1.29

30.88

1.1

22.30

8.16

u/ml

0.61

183

Disorders of tooth development and eruption

445

1988

1.85

30.58

1.1

0.88

3.72

u/ml

—

Other metabolic disorders

397

2149

1.91

30.37

1.1

1.18

2.17

u/ml

—

Symptoms and signs involving the urinary system

1814

10343

1.35

30.30

1.1

15.53

6.59

u/ml

0.35

153

Disorders of vitreous body and globe

1166

7850

1.45

30.14

1.1

6.88

3.67

u/ml

0.25

122

Injuries to the thorax

1012

6909

1.48

30.11

1.1

2.13

7.90

u/ml

0.83

104

Undetermined asthma, excluding more controls

357

1870

1.96

30.01

1.1

75.62

1.80

u/ml

—

Other eating disorders

236

1072

2.33

29.88

1.1

59.08

6.32

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

501

2920

1.76

29.68

1.1

7.74

1.97

u/ml

—

Other obstetric conditions, not elsewhere classified

1075

4689

1.49

29.66

1.1

4.66

12.02

u/ml

0.51

Allergic conjunctivitis

1639

11886

1.36

29.62

1.1

1.16

8.40

u/ml

1.66

191

Kela-code for severe mental illness

933

6300

1.51

29.59

1.1

1.28

8.92

u/ml

1.04

Vocal cord dysfunction

332

1520

2.00

29.46

1.1

1.28

1.60

u/ml

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1056

4592

1.49

29.35

1.1

4.88

12.18

u/ml

0.48

Undetermined asthma

357

1885

1.95

29.32

1.1

75.62

1.82

u/ml

—

Disorders of vitreous body

1135

7691

1.45

29.25

1.1

6.88

3.72

u/ml

0.24

120

Other (not insulin) diabetes medications

2330

10709

1.30

29.12

1.1

18.97

6.14

u/ml

0.51

176

Unspecified fall

1271

8975

1.41

29.08

1.1

6.78

9.47

u/ml

0.24

128

Endometriosis

1002

3972

1.51

29.06

1.1

2.25

9.62

u/ml

0.51

Diabetic retinopathy, strict definition

470

2384

1.80

29.05

1.2

1.1

20.76

16.91

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

968

6537

1.49

28.95

1.1

6.05

8.67

u/ml

0.16

Stomatitis and related lesions

553

3337

1.70

28.93

1.1

7.05

17.60

u/ml

0.48

Inflammatory diseases of female pelvic organs

1805

10001

1.34

28.92

1.1

1.03

7.31

u/ml

1.40

166

Disorders of psychological development

466

2489

1.80

28.92

1.1

1.30

17.65

u/ml

—

Ulcer of lower limb, not elsewhere classified

315

1604

2.02

28.77

1.1

55.40

1.19

u/ml

—

Neoplasms

2193

8929

1.31

28.66

1.1

20.39

12.06

u/ml

0.30

122

Implicit viral Sepsis

498

2930

1.74

28.51

1.1

66.50

8.41

u/ml

—

Sicca syndrome [Sjögren]

267

1292

2.15

28.50

1.1

1.77

1.94

u/ml

—

Injuries to the knee and lower leg

3174

14191

1.25

28.38

1.1

10.89

10.04

u/ml

0.04

216

Other disorders of fluid, electrolyte and acid-base balance

672

4055

1.60

28.30

1.1

0.88

8.15

u/ml

0.63

Gonarthrosis [arthrosis of knee](FG)

1651

7107

1.36

28.27

1.1

1.66

11.62

u/ml

1.45

108

Viral Sepsis

498

2938

1.73

28.23

1.1

66.50

8.41

u/ml

—

Polycystic ovarian syndrome, consortium definition

2144

9798

1.31

28.03

1.1

13.71

4.92

u/ml

0.61

154

Non-allergic asthma (mode), excluding more controls

513

3026

1.71

28.01

1.1

0.79

7.45

u/ml

—

Non-allergic asthma (mode)

513

3031

1.71

27.84

1.1

0.79

7.46

u/ml

—

Bacterial pneumonia, not elsewhere classified

912

5455

1.49

27.52

1.1

7.71

5.22

u/ml

—

Cholecystectomy

1694

11017

1.34

27.48

1.1

1.52

6.16

u/ml

1.17

170

Recurrent aphthous stomatitis , including avohilmo

417

2366

1.82

27.42

1.1

6.77

3.04

u/ml

—

Sleep apnoea

2246

11325

1.30

27.41

1.1

12.09

6.19

u/ml

0.23

178

Gonarthrosis

1386

5709

1.40

27.41

1.1

1.80

15.09

u/ml

1.46

Migraine without aura and triptan purchases

544

3323

1.68

27.30

1.1

1.20

16.72

u/ml

—

Hernia of abdominal wall, postoperative

417

2361

1.80

27.27

1.1

2.53

11.09

u/ml

—

Meniscus derangement

1220

5856

1.42

27.18

1.1

1.10

14.75

u/ml

1.58

Acute sinusitis

1383

9397

1.38

27.17

1.1

22.66

7.99

u/ml

0.38

140

Intracranial trauma

1490

7726

1.37

27.15

1.1

2.05

13.38

u/ml

1.30

102

Injury, poisoning and certain other consequences of external causes

1537

5661

1.38

26.96

1.1

3.26

7.38

u/ml

0.54

Eating disorders

397

2234

1.84

26.94

1.1

39.68

4.47

u/ml

—

Other acute lower respiratory infections

1324

9222

1.38

26.76

1.1

3.83

10.05

u/ml

0.73

120

Fall on same level involving ice and snow

1426

10582

1.36

26.40

1.1

1.50

5.78

u/ml

0.97

157

Renal tubulo-interstitial diseases

2202

12843

1.29

26.35

1.1

14.46

8.04

u/ml

0.29

189

Other heart diseases

1289

6086

1.40

26.35

1.1

24.02

9.63

u/ml

0.50

Vasomotor and allergic rhinitis

1066

7409

1.43

26.29

1.1

25.42

9.73

u/ml

0.27

123

Fracture of lumbar spine and pelvis

489

2922

1.70

26.23

1.1

11.93

1.49

u/ml

—

Triptan medication for migraine, single purchase ok

2152

11377

1.29

26.19

1.1

1.15

12.68

u/ml

2.22

175

Migraine, single triptan purchase ok & required. ICD-code if available is included

2152

11377

1.29

26.19

1.1

1.15

12.68

u/ml

2.22

175

Bacterial pneumoniae

956

5837

1.46

26.12

1.1

28.26

5.02

u/ml

—

Fracture of foot, except ankle

655

4222

1.58

26.05

1.1

0.93

7.78

u/ml

—

Other and unspecified nonorganic psychotic disorders

533

3273

1.67

26.03

1.1

1.25

10.22

u/ml

—

Immunodeficiencies

172

724

2.51

25.98

1.4

1.1

100.48

2.26

u/ml

—

Cholelithiasis, broad definition with cholecystitis

2080

10891

1.30

25.82

1.1

1.53

7.86

u/ml

1.56

166

Bleeding

1920

10533

1.31

25.70

1.1

4.42

11.00

u/ml

0.73

147

Fibroblastic disorders

480

2877

1.70

25.55

1.1

1.23

13.18

u/ml

—

Suicide or other Intentional self-harm

662

4297

1.57

25.54

1.1

1.20

8.77

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

637

4023

1.59

25.49

1.1

4.77

6.58

u/ml

0.15

Sequelae of external causes of morbidity and mortality

607

3868

1.60

25.35

1.1

2.16

13.20

u/ml

—

Abnormal involuntary movements

353

1951

1.86

25.32

1.1

4.86

1.89

u/ml

—

Influenza and pneumonia

2794

14349

1.25

25.06

1.1

14.78

9.36

u/ml

0.24

222

Cholelithiasis

2005

10752

1.30

25.03

1.1

1.56

7.95

u/ml

1.55

164

STROKE

1254

6194

1.39

25.03

1.1

47.80

2.80

u/ml

0.81

Heart failure, not strict

1666

8589

1.33

24.91

1.1

25.30

9.28

u/ml

0.55

127

Disorders of sclera, cornea, iris and ciliary body

1340

9944

1.36

24.85

1.1

4.08

10.72

u/ml

0.70

143

Bacterial pneumonia (organism specified)

988

6309

1.44

24.75

1.1

28.26

4.47

u/ml

—

Disorders of lens

1476

6867

1.36

24.68

1.1

1.62

9.24

u/ml

1.18

120

Other extrapyramidal and movement disorders in other diseases

553

3476

1.62

24.53

1.1

2.20

1.61

u/ml

—

Other bacterial diseases

2308

12306

1.27

24.51

1.1

23.67

8.29

u/ml

0.63

174

Congenital malformations, deformations and chromosomal abnormalities

1756

12483

1.31

24.47

1.1

3.31

13.63

u/ml

1.69

181

Trigger finger

353

1973

1.83

24.32

1.1

40.98

12.88

u/ml

—

Atrial fibrillation and flutter with reimbursement

565

2232

1.64

24.25

1.1

60.40

3.92

u/ml

—

Implicit bacterial Sepsis

936

5660

1.45

24.04

1.1

2.30

4.73

u/ml

0.39

Disorders of ocular muscles, binocular movement, accommodation and refraction

1285

9452

1.37

23.92

1.1

38.26

8.64

u/ml

0.60

139

Transport accidents

1157

7236

1.39

23.90

1.1

5.17

9.24

u/ml

0.47

129

Alcohol use disorder, Swedish definition

1183

7932

1.38

23.72

1.1

15.81

8.42

u/ml

0.20

110

Fissure and fistula of anal and rectal regions

537

3378

1.62

23.65

1.1

3.97

12.93

u/ml

0.62

Other specified/unspecified systemic involvement of connective tissue

184

830

2.32

23.61

1.1

1.72

0.86

u/ml

—

Certain disorders involving the immune mechanism

469

2864

1.67

23.49

1.2

1.1

86.26

2.25

u/ml

1.17

Selective deficiency of immunoglobulin A [IgA]y

7.19

23.48

1.9

1.1

100.47

—

u/ml

—

Mouth breathing

937

6614

1.44

23.47

1.1

2.07

16.27

u/ml

1.49

Biological medication for rheuma

482

2968

1.66

23.43

1.1

27.83

20.80

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

353

1998

1.81

23.38

1.1

0.99

1.94

u/ml

—

Other and unspecified effects of external causes

757

5151

1.50

23.36

1.1

33.71

2.83

u/ml

—

Menorrhagia

950

3679

1.46

23.27

1.1

10.45

11.28

u/ml

0.02

Sequelae of injuries, of poisoning and of other consequences of external causes

566

3625

1.59

23.19

1.1

1.19

9.05

u/ml

—

Diseases of salivary glands

806

5560

1.47

23.13

1.1

3.36

6.10

u/ml

0.26

L04AD Calcineurin inhibitors

312

1713

1.88

23.05

1.1

85.50

1.35

u/ml

—

Psoriasis

670

4463

1.53

22.91

1.1

24.32

11.13

u/ml

0.35

Spondylolisthesis/Spondylolysis

424

2538

1.71

22.88

1.1

7.78

8.08

u/ml

—

Extrapyramidal and movement disorders

830

5765

1.46

22.87

1.1

1.65

4.46

u/ml

0.48

Tinnitus

560

3591

1.59

22.85

1.1

1.18

6.58

u/ml

0.56

Noninflammatory disorders of female genital tract

1271

4681

1.38

22.83

1.1

2.95

14.35

u/ml

0.75

Disorders of continuity of bone

275

1456

1.95

22.73

1.1

2.50

0.84

u/ml

—

Polyarthrosis

451

2543

1.68

22.72

1.1

0.92

1.91

u/ml

0.99

Cutaneous abscess, furuncle and carbuncle

641

4245

1.54

22.56

1.1

30.48

12.66

u/ml

—

Primary adrenocortical insufficiency

141

4.62

22.54

1.4

1.0

—

Diabetes mellitus in pregnancy

983

4471

1.43

22.52

1.1

2.33

6.35

u/ml

—

Congenital malformations, deformations and chromosomal abnormalities

1600

11761

1.31

22.39

1.1

3.17

12.24

u/ml

1.38

169

Other disorders of eyelid

947

6427

1.42

22.38

1.1

34.86

3.89

u/ml

0.42

100

Procreative management

918

5417

1.44

22.37

1.1

2.22

11.04

u/ml

—

Implicit bacterial Sepsis

833

5137

1.45

22.27

1.1

2.37

4.92

u/ml

0.35

Memory loss

210

1019

2.13

22.18

1.1

—

0.90

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

418

1343

1.74

22.13

1.1

1.16

6.66

u/ml

—

Ischaemic heart disease, wide definition

1644

7832

1.31

22.09

1.1

12.18

7.51

u/ml

0.18

119

Enlarged lymph nodes

394

2337

1.72

22.04

1.1

7.02

18.25

u/ml

—

Other disorders of veins

960

6853

1.41

21.98

1.1

19.56

7.45

u/ml

0.28

101

Coxarthrosis

1002

4730

1.41

21.95

1.1

0.92

15.77

u/ml

1.60

Sulfasalazine

702

4762

1.50

21.94

1.1

0.92

5.57

u/ml

—

Schizophrenia or delusion

783

5427

1.46

21.90

1.1

1.16

7.28

u/ml

0.77

Acute bronchitis

964

6790

1.41

21.87

1.1

2.48

12.39

u/ml

0.98

Chronic periodontitis, complicated

1185

8722

1.36

21.87

1.1

2.82

8.22

u/ml

0.85

144

GI-bleeding

638

4243

1.52

21.85

1.1

1.57

1.01

u/ml

0.86

Erosion of teeth , including avohilmo

669

4511

1.51

21.68

1.1

1.83

7.78

u/ml

0.54

Keratitis

856

6043

1.44

21.64

1.1

4.53

9.08

u/ml

0.36

Other diseases of the digestive system

638

4253

1.52

21.62

1.1

1.57

1.03

u/ml

0.84

Viral and other specified intestinal infections

644

4207

1.52

21.59

1.1

1.04

9.33

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

417

2528

1.69

21.54

1.1

2.77

1.74

u/ml

—

Schizophrenia, schizotypal and delusional disorders

783

5448

1.46

21.47

1.1

1.16

10.39

u/ml

1.06

Lichen simplex chronicus and prurigo

171

778

2.28

21.41

1.1

2.54

1.72

u/ml

—

Acute tubulo-interstitial nephritis

1545

10286

1.31

21.39

1.1

14.12

7.17

u/ml

0.23

152

Paralytic ileus and intestinal obstruction

502

3183

1.60

21.31

1.1

1.03

13.04

u/ml

0.95

Rheumatoid arthritis, including avohilmo

885

6308

1.42

21.20

1.1

15.14

7.67

u/ml

0.21

Mixed connective tissue disease

193

927

2.17

21.18

1.1

1.67

0.96

u/ml

—

Lactose intolerance

118

459

2.73

21.17

1.2

1.1

—

1.03

—

Overexertion and strenuous or repetitive movements

262

1398

1.93

21.15

1.1

—

0.87

—

Benign neoplasm: Colon, unspecified

515

3298

1.59

21.12

1.1

8.17

6.33

u/ml

—

All pneumoniae

2598

14195

1.23

21.05

1.1

17.53

9.28

u/ml

0.33

224

Diseases of male genital organs

950

3388

1.43

21.04

1.1

34.22

13.97

u/ml

—

Impingement syndrome of shoulder

510

3263

1.59

20.97

1.1

0.92

12.75

u/ml

0.98

Lichen ruber planus, wide definition including periferal and oral lichen planus

521

3370

1.58

20.56

1.1

1.42

7.93

u/ml

—

Diabetic retinopathy, excluding more controls

661

2472

1.53

20.55

1.2

1.1

15.20

9.55

u/ml

—

Exclusions for E4_PCOS_BROAD

479

3041

1.61

20.55

1.1

1.06

11.89

u/ml

—

Benign neoplasm: Ascending colon

300

1685

1.82

20.45

1.1

2.21

1.91

u/ml

—

Benign neoplasm: Rectum

382

2294

1.70

20.45

1.1

1.38

1.69

u/ml

—

1326

8883

1.33

20.41

1.1

13.84

7.94

u/ml

0.18

127

Tonsillectomy and adenotomy

1633

8873

1.29

20.17

1.1

5.24

11.75

u/ml

0.60

141

Bacterial Sepsis

971

6043

1.39

19.94

1.1

2.15

4.93

u/ml

0.50

Erysipelas

1597

9512

1.29

19.92

1.1

18.49

6.51

u/ml

0.31

138

Psoriasis vulgaris

431

2688

1.64

19.89

1.1

47.26

10.32

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

2566

14152

1.23

19.89

1.1

17.53

9.32

u/ml

0.33

223

Abrasion of teeth

827

5901

1.42

19.80

1.1

14.33

8.06

u/ml

0.18

Striking against or struck by other objects

828

5903

1.42

19.77

1.1

4.68

10.29

u/ml

—

Sequelae with surgical and medical care as external cause

465

2959

1.60

19.72

1.1

2.45

1.69

u/ml

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

476

3043

1.59

19.72

1.1

1.15

6.56

u/ml

—

Emotional disorders and disorders of social functioning with onset specific to childhood

238

1247

1.97

19.71

1.2

78.86

5.44

u/ml

—

Hyperplasia of prostate

549

2009

1.57

19.65

1.1

2.04

18.19

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

406

2504

1.66

19.65

1.1

70.84

2.45

u/ml

—

Coxarthrosis [arthrosis of hip](FG)

1092

5686

1.36

19.65

1.1

0.92

12.18

u/ml

1.42

Plantar fascial fibromatosis

245

1310

1.92

19.64

1.1

1.46

2.89

u/ml

—

Artrosis, including avohilmo

1891

8204

1.27

19.61

1.1

1.08

11.81

u/ml

1.72

112

Cervicocranial syndrome

266

1461

1.87

19.57

1.1

1.03

2.71

u/ml

—

Seropositive rheumatoid arthritis

566

3752

1.53

19.50

1.1

23.04

6.61

u/ml

—

Inflammatory bowel disease

776

5497

1.43

19.34

1.1

29.29

5.51

u/ml

0.49

Urticaria and erythema

975

7177

1.38

19.32

1.1

1.45

9.25

u/ml

0.98

100

Mycoses

622

4233

1.49

19.25

1.1

1.73

12.02

u/ml

0.84

Other cataract

932

5124

1.39

19.15

1.1

6.01

8.88

u/ml

0.18

Other neurological diseases

1582

9745

1.29

19.15

1.1

2.57

8.12

u/ml

0.92

149

Substance abuse

1293

9309

1.32

19.12

1.1

21.82

7.40

u/ml

0.44

136

Tumor necrosis factor alpha inhibitors

426

2680

1.63

19.10

1.1

30.83

23.30

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

421

2637

1.63

19.07

1.1

1.30

7.49

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

512

2290

1.57

19.02

1.1

23.75

3.90

u/ml

0.41

Acetic acid derivatives and related substances

619

2139

1.52

18.88

1.1

1.01

6.00

u/ml

—

Senile cataract

1272

5917

1.33

18.84

1.1

1.82

4.47

u/ml

—

104

1245

8589

1.32

18.79

1.1

15.15

8.00

u/ml

0.21

120

Other general symptoms and signs

178

861

2.14

18.74

1.1

—

46.64

u/ml

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1013

7532

1.36

18.74

1.1

2.72

7.54

u/ml

0.65

108

Diseases of inner ear

1197

8810

1.33

18.72

1.1

1.68

6.25

u/ml

0.87

138

Injuries to the shoulder and upper arm

1985

12911

1.25

18.71

1.1

13.38

7.79

u/ml

0.18

195

Atrial fibrillation and flutter

674

2996

1.48

18.67

1.1

33.44

3.50

u/ml

0.48

Fracture of rib(s), sternum and thoracic spine

605

4117

1.49

18.66

1.1

2.02

11.15

u/ml

0.79

Bacterial infection, other or unspecified

1261

8157

1.32

18.61

1.1

15.76

7.68

u/ml

0.29

112

Adverse effects, not elsewhere classified

539

3598

1.53

18.50

1.1

41.81

3.38

u/ml

—

Rash and other nonspecific skin eruption

262

1464

1.84

18.36

1.1

0.93

1.28

u/ml

—

772

5043

1.42

18.31

1.1

22.81

5.03

u/ml

0.45

Misadventures to patients during surgical and medical care

335

2005

1.71

18.28

1.1

1.14

1.83

u/ml

—

Hard cardiovascular diseases

1902

9094

1.26

18.24

1.1

25.96

7.96

u/ml

0.65

133

Erysipelas

1163

7813

1.33

18.22

1.1

23.64

7.81

u/ml

0.31

110

Periapical abscess

1046

7851

1.35

18.18

1.1

8.77

10.08

u/ml

0.05

113

Lactose intolerance, other/unspecified

102

399

2.71

18.16

1.2

1.1

—

1.03

—

Renal failure

866

5567

1.39

18.08

1.1

37.41

4.72

u/ml

0.65

Thyrotoxicosis

627

4330

1.47

18.08

1.1

1.49

2.14

u/ml

0.34

Allergic rhinitis

892

6475

1.38

18.03

1.1

26.80

9.17

u/ml

0.29

Infections with a predominantly sexual mode of transmission

1099

7745

1.34

17.99

1.1

11.39

10.76

u/ml

0.02

108

Coronary atherosclerosis

1316

6400

1.31

17.96

1.1

13.15

6.06

u/ml

0.24

Arthropod-borne viral fevers and viral haemorrhagic fevers

440

2827

1.59

17.96

1.1

59.25

11.13

u/ml

—

Cerebrovascular diseases (FINNGEN)

695

3427

1.45

17.96

1.1

72.79

3.15

u/ml

—

Type 2 diabetes, strict (exclude DM1)

2168

10366

1.24

17.95

1.1

22.51

6.30

u/ml

0.55

169

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1018

7600

1.35

17.84

1.1

4.02

11.00

u/ml

0.77

116

Deviated nasal septum

655

4559

1.45

17.84

1.1

1.22

14.88

u/ml

—

Ischemic heart diseases

1849

8901

1.26

17.82

1.1

26.93

8.30

u/ml

0.68

126

Mental and behavioural disorders due to psychoactive substance use

1328

9553

1.30

17.79

1.1

21.82

7.21

u/ml

0.45

140

Type 2 diabetes, definitions combined

2157

10319

1.24

17.76

1.1

22.51

6.30

u/ml

0.55

169

Gout

457

2596

1.57

17.72

1.1

1.17

16.68

u/ml

—

Disorders of vestibular function (Vertigo)

1033

7639

1.34

17.70

1.1

1.78

6.72

u/ml

0.81

121

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1080

5110

1.35

17.69

1.1

13.82

4.71

u/ml

0.33

Brachial plexus disorders

251

1400

1.84

17.68

1.1

2.10

2.68

u/ml

—

Alcohol abuse, main dg, excluding more controls

319

1901

1.71

17.62

1.1

1.44

10.45

u/ml

—

Thyrotoxicosis, other and/or unspecified

505

3359

1.53

17.61

1.1

1.56

1.66

u/ml

—

Hallux valgus (acquired)

753

3847

1.42

17.59

1.1

1.14

7.88

u/ml

—

Internal derangement of knee

815

5892

1.39

17.44

1.1

3.14

15.42

u/ml

1.28

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2472

13987

1.21

17.44

1.1

17.53

7.46

u/ml

0.44

218

Angina pectoris

1138

5749

1.33

17.37

1.1

19.78

6.68

u/ml

0.36

Hyperlipidaemia, other/unspecified

723

4741

1.42

17.20

1.1

1.90

7.43

u/ml

—

Skin changes due to chronic exposure to nonionizing radiation

715

4690

1.42

17.19

1.1

25.48

5.34

u/ml

0.46

Injuries to the wrist and hand

2549

14721

1.21

17.15

1.1

28.32

8.27

u/ml

0.55

239

Benign neoplasm: Transverse colon

230

1261

1.87

17.11

1.1

2.29

1.32

u/ml

—

Injuries to the head

2839

14670

1.20

17.10

1.1

7.75

10.68

u/ml

0.18

217

Fracture of lower leg, including ankle

1287

9930

1.29

16.92

1.1

4.44

8.95

u/ml

0.49

139

Urticaria

807

5898

1.39

16.86

1.1

1.58

11.38

u/ml

—

Percutaneous Coronary Intervention

1735

8523

1.26

16.85

1.1

20.37

8.55

u/ml

0.41

122

Emergency coronary revascularization (for ACS)

1849

9070

1.25

16.85

1.1

18.04

9.95

u/ml

0.30

130

Other disorders of ear

2173

11692

1.23

16.84

1.1

1.88

10.28

u/ml

1.60

165

All chronic kidney diseases

1162

7287

1.32

16.83

1.1

25.94

8.46

u/ml

0.46

104

Actinic keratosis

688

4518

1.43

16.83

1.1

27.12

5.41

u/ml

0.46

Abnormal findings on diagnostic imaging of other body structures

330

2013

1.68

16.82

1.1

1.50

1.87

u/ml

—

Female infertility, cervical, vaginal, other or unspecified origin

758

3529

1.42

16.81

1.1

2.11

11.72

u/ml

0.56

Diplopia

301

1795

1.71

16.71

1.1

6.03

1.23

u/ml

—

Other maternal disorders predominantly related to pregnancy

1582

7891

1.27

16.63

1.1

3.71

5.15

u/ml

0.24

119

Mental and behavioural disorders due to alcohol, excluding acute intoxication

901

6671

1.36

16.59

1.1

24.39

9.75

u/ml

0.26

Benign neoplasm: Stomach

226

1246

1.86

16.57

1.1

0.82

1.33

u/ml

—

Ganglion

492

3301

1.51

16.42

1.1

0.88

13.60

u/ml

0.97

Hypokalaemia

269

1569

1.75

16.20

1.1

0.93

1.66

u/ml

—

Lesion of ulnar nerve

300

1802

1.70

16.17

1.1

18.96

2.26

u/ml

0.42

Other menopausal disorders

685

2721

1.44

16.15

1.1

1.82

2.42

u/ml

—

Acute renal failure

407

2634

1.57

16.05

1.1

55.26

7.24

u/ml

—

Other and unspecified disorders of vitreous body

892

6573

1.35

16.05

1.1

1.87

3.95

u/ml

0.39

100

Coronary revascularization (ANGIO or CABG)

1729

8530

1.25

16.02

1.1

19.72

8.49

u/ml

0.40

123

Other or unspecified ileus, impaction or obstruction

338

2096

1.64

15.94

1.1

1.05

8.62

u/ml

0.55

Heart failure and antihypertensive medication

489

2125

1.52

15.93

1.1

62.19

3.56

u/ml

—

Lateral epicondylitis

298

1795

1.69

15.91

1.1

0.77

13.54

u/ml

—

Disorders of refraction and accommodation

723

5223

1.40

15.89

1.1

49.78

7.28

u/ml

—

Other problems related to primary support group, including family circumstances

387

2427

1.59

15.82

1.1

17.12

17.56

u/ml

—

Ulcerative colitis

572

3983

1.46

15.81

1.1

29.15

1.86

u/ml

0.53

Infections with a predominantly sexual mode of transmission

817

6036

1.37

15.81

1.1

18.95

12.75

u/ml

0.12

Exclusions for E4_PCOS_CONSORTIUM

2015

10362

1.23

15.81

1.1

10.90

9.67

u/ml

0.04

158

Type 2 diabetes, definitions combined, including avohilmo

2157

10361

1.22

15.80

1.1

10.95

6.36

u/ml

0.20

167

Anogenital herpesviral [herpes simplex] infection

325

2012

1.66

15.75

1.1

1.02

2.58

u/ml

—

Obesity due to excess calories

1171

9113

1.30

15.75

1.1

1.03

12.10

u/ml

1.58

127

Conjunctivitis (acute, non atopic)

724

5239

1.40

15.75

1.1

21.77

7.48

u/ml

0.30

Glucosamine medication

967

5829

1.34

15.67

1.1

1.36

4.33

u/ml

0.51

All influenza

577

4032

1.45

15.61

1.1

47.13

7.72

u/ml

0.65

Other hammer toe(s) (acquired)

367

2157

1.60

15.40

1.1

1.00

1.67

u/ml

—

Mental and behavioural disorders due to alcohol

1069

7913

1.31

15.39

1.1

19.79

8.18

u/ml

0.26

110

Bacterial intestinal infections, IBD co-morbidities

393

2551

1.57

15.37

1.1

1.10

1.75

u/ml

—

Psoriatic and enteropathic arthropathies

267

1579

1.73

15.32

1.1

7.42

2.95

u/ml

—

Gonarthrosis,primary

1844

9265

1.23

15.27

1.1

1.72

8.70

u/ml

1.39

151

Bacterial infection, other or unspecified

1123

7550

1.30

15.25

1.1

18.69

7.87

u/ml

0.34

109

Triptan medication for migraine, min. 3 purchases

1569

9646

1.25

15.24

1.1

1.16

10.19

u/ml

1.59

149

Cluster headache, wide

115

514

2.33

15.23

1.1

—

0.84

—

Cluster headache, strict

110

483

2.38

15.21

1.1

—

0.84

—

Enthesopathies of lower limb, excluding foot

488

3324

1.49

15.14

1.1

73.04

8.11

u/ml

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

181

3257

0.54

15.14

1.1

0.97

6.59

u/ml

—

Injuries to the neck

545

3795

1.46

15.12

1.1

51.07

2.57

u/ml

—

Seronegative rheumatoid arthritis

270

1608

1.72

15.12

1.1

0.92

2.20

u/ml

—

Substance use, excluding alcohol

469

3176

1.50

15.04

1.1

15.27

9.24

u/ml

—

Biguanides

2198

11135

1.21

15.04

1.1

20.91

4.99

u/ml

0.60

178

Early onset COPD, excluding more controls

383

2480

1.56

15.03

1.1

56.18

8.61

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

454

3057

1.51

15.01

1.1

1.82

2.97

u/ml

—

Disorders of breast

1295

9309

1.28

15.00

1.1

5.64

3.42

u/ml

0.21

132

Other disorders of bladder

232

1327

1.78

14.97

1.0

1.1

1.86

0.94

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2167

11537

1.21

14.89

1.1

15.81

8.16

u/ml

0.32

161

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2447

13405

1.20

14.82

1.1

20.46

9.17

u/ml

0.50

200

Abnormal findings on diagnostic imaging of lung

934

6809

1.33

14.77

1.1

12.42

7.76

u/ml

0.20

103

Intracranial injury

1370

10345

1.26

14.75

1.1

2.05

11.23

u/ml

1.50

138

Other viral diseases

1004

7670

1.31

14.72

1.1

23.43

7.91

u/ml

0.33

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1078

6677

1.30

14.69

1.1

36.91

5.62

u/ml

0.68

111

Other and unspecified visual disturbances

251

1480

1.74

14.67

1.1

56.68

1.28

u/ml

—

Dermatophytosis

1393

11149

1.26

14.66

1.1

6.28

9.58

u/ml

0.24

161

Injuries to the elbow and forearm

1776

12819

1.23

14.61

1.1

5.70

10.30

u/ml

0.53

196

Oxicams

449

1685

1.53

14.61

1.1

0.80

7.02

u/ml

0.97

Thyrotoxicosis with diffuse goitre

362

2340

1.58

14.57

1.1

1.88

1.89

u/ml

—

Covid-19 suspected case

559

3950

1.44

14.36

1.1

29.94

2.70

u/ml

0.55

Superficial injury of lower leg

614

4414

1.41

14.26

1.1

5.47

1.45

u/ml

0.79

Other symptoms and signs involving the digestive system and abdomen

388

2556

1.54

14.25

1.1

1.06

2.27

u/ml

—

Specific development disorders of scholastic skills

190

1040

1.89

14.05

1.1

1.2

—

5.73

—

Disorder of lipoprotein metabolism, unspecified

249

1479

1.71

14.05

1.1

42.45

0.98

u/ml

—

Anorexia (incl.atypical)

199

1115

1.84

14.03

1.2

1.1

50.67

5.88

u/ml

—

Childhood asthma (age<16)

435

2307

1.51

14.02

1.1

1.21

2.79

u/ml

—

Childhood asthma (age<16), excluding more controls

435

2306

1.51

14.02

1.1

1.21

2.72

u/ml

—

Persons encountering health services in circumstances related to reproduction

1461

7925

1.25

13.99

1.1

6.40

13.28

u/ml

0.62

120

Neuralgia and neuritis, unspecified

126

604

2.15

13.98

1.1

—

0.87

—

Female infertility

807

3648

1.36

13.98

1.1

2.23

11.35

u/ml

0.55

Primary biliary cholangitis (PBC)

249

2.89

13.84

1.1

1.0

—

Candidiasis

333

2138

1.59

13.84

1.1

1.03

1.49

u/ml

—

Propionic acid derivatives

708

2581

1.39

13.82

1.1

2.09

14.09

u/ml

—

Other viral diseases, not elsewhere classified

703

5166

1.37

13.80

1.1

3.57

8.49

u/ml

0.36

Chronic kidney disease

538

3722

1.43

13.78

1.1

21.81

5.94

u/ml

—

Hypo-osmolality and hyponatraemia

338

2164

1.58

13.74

1.1

0.85

1.70

u/ml

—

Pregnancy examination and test

497

2127

1.48

13.73

1.1

2.43

u/ml

—

Adalimumab

258

1562

1.69

13.72

1.1

39.20

1.43

u/ml

—

Superficial injury of wrist and hand

527

3725

1.44

13.57

1.1

4.43

9.03

u/ml

—

Female genital prolapse

693

2854

1.39

13.57

1.1

1.45

2.23

u/ml

0.44

Glomerular diseases

378

2508

1.53

13.46

1.1

20.64

11.01

u/ml

—

Benign neoplasm: Sigmoid colon

374

2479

1.53

13.37

1.1

0.98

1.75

u/ml

0.83

Fracture of shoulder and upper arm

810

6132

1.33

13.33

1.1

1.70

5.68

u/ml

—

Other inflammation of vagina/vulva

125

612

2.14

13.33

1.1

—

0.97

—

Alcohol use disorder, ICD-based

816

6189

1.33

13.32

1.1

26.43

9.73

u/ml

0.27

Anti-inflammatory and antirheumatic products, non-steroids

704

2581

1.38

13.30

1.1

2.33

14.09

u/ml

—

Major coronary heart disease event

1806

9001

1.22

13.29

1.1

26.93

8.14

u/ml

0.69

129

Viral infections characterized by skin and mucous membrane lesions

979

7616

1.30

13.21

1.1

22.12

11.30

u/ml

0.23

107

5-aminosalicylic acid

498

3500

1.44

13.19

1.1

47.67

1.65

u/ml

—

Posteruptive colour changes of dental hard tissues

6.41

13.10

1.1

—

Unspecified lump in breast

401

2716

1.51

13.05

1.1

17.53

1.73

u/ml

—

Medical abortion

1735

7751

1.22

13.04

1.1

1.52

3.67

u/ml

0.91

120

Diabetic retinopathy

745

3461

1.36

12.96

1.2

1.1

13.39

13.54

u/ml

—

Paroxysmal tachycardia

531

3163

1.42

12.78

1.1

31.31

3.34

u/ml

0.58

Benign paroxysmal vertigo

624

4582

1.38

12.77

1.1

2.23

1.79

u/ml

0.13

Diabetic maculopathy

304

1834

1.60

12.77

1.2

1.1

20.52

12.34

u/ml

—

Pneumonia, organism unspecified

2182

12929

1.19

12.75

1.1

18.52

7.61

u/ml

0.45

197

Other disorders of patella

399

2712

1.49

12.65

1.1

1.89

12.86

u/ml

—

Fracture of femur

481

3065

1.44

12.52

1.1

3.18

1.48

u/ml

—

Melanocytic naevi

697

5224

1.35

12.50

1.1

26.93

2.20

u/ml

0.51

Localized swelling, mass and lump of skin and subcutaneous tissue

695

5213

1.35

12.37

1.1

1.05

6.18

u/ml

0.82

Transient ischemic attack

999

6341

1.29

12.35

1.1

3.81

1.88

u/ml

0.34

101

Seborrhoeic keratosis

436

3032

1.46

12.27

1.1

52.76

1.62

u/ml

0.75

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

603

4433

1.38

12.26

1.1

1.06

7.06

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

603

4433

1.38

12.26

1.1

1.06

7.06

u/ml

—

Zoster [herpes zoster]

1052

8207

1.27

12.26

1.1

1.90

4.64

u/ml

0.50

128

Superficial injury of head

535

3864

1.40

12.13

1.1

1.06

8.55

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

407

2803

1.47

12.11

1.1

22.94

1.66

u/ml

—

Polyp of the female genital tract

745

3215

1.35

12.11

1.1

1.04

2.96

u/ml

—

False labour

863

4140

1.32

12.09

1.1

18.47

12.22

u/ml

0.14

Injuries to the hip and thigh

966

6873

1.28

11.97

1.1

4.19

7.92

u/ml

0.38

102

Pollen allergy

560

4041

1.39

11.94

1.1

37.57

10.89

u/ml

0.31

Benign neoplasm: Caecum

214

1280

1.71

11.93

1.1

0.93

1.28

u/ml

—

Epilepsy

675

5059

1.34

11.82

1.1

1.16

12.68

u/ml

1.02

Dysplasia of cervi uteri

626

3350

1.37

11.80

1.1

32.29

10.94

u/ml

—

Colectomy operation

327

2168

1.53

11.75

1.1

11.90

1.73

u/ml

—

Seropositive rheumatoid arthritis, wide

566

4151

1.38

11.73

1.1

23.04

1.76

u/ml

—

Intestinal stricture

594

4390

1.37

11.66

1.1

1.05

10.16

u/ml

0.87

Acute appendicitis

1618

12600

1.21

11.63

1.1

9.05

9.62

u/ml

0.02

188

Unspecified haematuria

768

4871

1.32

11.55

1.1

32.56

10.83

u/ml

0.41

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

554

4062

1.38

11.52

1.1

23.04

1.78

u/ml

—

Other strabismus

563

4128

1.38

11.49

1.1

26.35

8.86

u/ml

0.32

Other hearing loss

510

3610

1.40

11.40

1.1

0.93

6.03

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

559

4116

1.38

11.32

1.1

23.04

1.76

u/ml

—

Otitis externa

512

3728

1.39

11.16

1.1

43.30

9.35

u/ml

—

Diseases of middle ear and mastoid

1461

9894

1.22

11.12

1.1

5.52

11.54

u/ml

0.63

143

Gout, FINNGEN

457

3252

1.42

11.11

1.1

1.17

11.69

u/ml

—

Idiopathic urticaria

310

2.48

11.10

1.1

—

1.04

—

Allergic contact dermatitis

330

2227

1.51

10.99

1.1

1.85

3.26

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

148

819

1.85

10.87

1.1

—

2.48

—

Appendicitis, broad definition

1714

13065

1.19

10.85

1.1

8.64

9.48

u/ml

0.04

199

Other skin changes

376

2608

1.46

10.83

1.1

1.00

1.79

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

322

2169

1.51

10.80

1.1

0.99

1.81

u/ml

—

Explicit Sepsis

896

6608

1.28

10.73

1.1

15.88

4.85

u/ml

0.34

Methotrexate

325

2197

1.50

10.72

1.1

26.01

1.93

u/ml

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

682

5220

1.32

10.64

1.1

23.16

7.27

u/ml

—

Diseases of appendix

1724

13127

1.19

10.62

1.1

8.64

9.44

u/ml

0.04

200

ILD medications: azathioprine

356

2455

1.47

10.62

1.1

14.06

1.87

u/ml

—

Fall on and from stairs and steps

564

4203

1.36

10.60

1.1

2.05

7.40

u/ml

—

Azathioprine

356

2459

1.47

10.53

1.1

14.06

1.76

u/ml

—

Endometriosis of pelvic peritoneum

403

2714

1.44

10.47

1.1

2.84

3.49

u/ml

—

Dislocation, sprain and strain of joints and ligaments at neck level

371

2587

1.46

10.46

1.1

59.18

2.37

u/ml

—

Postmenopausal bleeding

590

2336

1.36

10.34

1.1

1.07

1.74

u/ml

—

Diseases of external ear

738

5730

1.30

10.33

1.1

74.52

13.74

u/ml

—

Other benign neoplasms of skin

766

5978

1.29

10.28

1.1

6.34

8.29

u/ml

0.11

Primary_lymphoid and hematopoietic malignant neoplasms

453

3278

1.40

10.25

1.1

20.93

6.97

u/ml

—

Other abnormal products of conception

868

4529

1.28

10.23

1.1

16.32

5.27

u/ml

0.31

Use of pramipexole

438

3157

1.41

10.18

1.1

1.29

1.78

u/ml

—

Blepharochalasis

577

4346

1.34

10.10

1.1

1.18

5.53

u/ml

—

Gastroduodenal ulcer

427

3056

1.41

10.09

1.1

25.29

1.68

u/ml

—

Septicaemia

835

6166

1.28

10.09

1.1

18.32

8.74

u/ml

0.23

Fracture of forearm

1328

10098

1.21

10.04

1.1

5.85

5.69

u/ml

0.01

152

Other CVD

336

2315

1.47

10.00

1.1

2.14

1.15

u/ml

—

Haemorrhage in early pregnancy

708

5348

1.30

10.00

1.1

2.43

4.27

u/ml

0.31

Liquid cancers, helper endpoint

751

5107

1.29

9.97

1.1

17.56

9.89

u/ml

0.18

Other septicaemia

733

5489

1.29

9.94

1.1

19.94

9.24

u/ml

0.24

AV-block

298

1753

1.51

9.92

1.1

3.84

1.02

u/ml

—

Acute appendicitis, no complications

1276

10542

1.21

9.76

1.1

11.73

8.60

u/ml

0.11

151

Other and unspecified tonsillitis

866

5792

1.27

9.75

1.1

2.91

13.20

u/ml

1.06

Reactive arthropathies

188

1149

1.67

9.73

1.1

40.72

22.74

u/ml

—

Other disorders of bone

445

3253

1.39

9.55

1.1

1.32

10.64

u/ml

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

448

3284

1.39

9.52

1.1

1.22

3.31

u/ml

—

Other and unspecified urticaria

484

3595

1.37

9.42

1.1

1.87

10.13

u/ml

—

Hernia of abdominal wall

892

7169

1.25

9.38

1.1

1.94

10.13

u/ml

1.16

112

Other noninflammatory disorders of uterus, except cervix

473

2338

1.38

9.36

1.1

13.37

1.74

u/ml

—

Strabismus

637

4916

1.31

9.26

1.1

26.35

8.24

u/ml

0.34

Impotence

427

2.08

9.17

1.2

1.1

—

0.76

—

IBD patients in KELA-register

509

3824

1.35

9.14

1.1

12.63

1.93

u/ml

—

Ventral hernia

459

3395

1.37

9.12

1.1

1.05

6.84

u/ml

—

Gastric ulcer

294

2018

1.47

8.98

1.1

35.70

1.70

u/ml

—

Colonic or urogenital fistula

548

4176

1.33

8.91

1.1

3.79

11.60

u/ml

0.57

Other degenerative diseases of the nervous system

511

2864

1.34

8.83

1.1

1.03

4.25

u/ml

—

Postmenopausal atrophic vaginitis

578

2424

1.33

8.77

1.1

0.89

1.74

u/ml

—

Suppurative and unspecified otitis media

945

6821

1.24

8.74

1.1

4.36

14.11

u/ml

0.86

Panniculitis affecting regions of neck and back

416

2.08

8.72

1.1

—

0.83

—

Open wound of ankle and foot

228

1503

1.54

8.61

1.1

47.60

3.43

u/ml

—

Ascites

139

814

1.74

8.51

1.1

1.0

1.23

0.91

u/ml

—

Contraceptive management

956

5464

1.24

8.50

1.1

8.56

7.52

u/ml

0.05

Pregnancy with abortive outcome

1756

7860

1.17

8.48

1.1

2.23

3.88

u/ml

0.59

122

Nonsuppurative otitis media

649

4401

1.29

8.46

1.1

9.70

8.11

u/ml

—

Corneal ulcer

390

2855

1.38

8.36

1.1

1.14

10.35

u/ml

0.63

Other specified/unspecified bacterial intestinal infections

146

873

1.71

8.34

1.1

—

1.61

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

173

1081

1.64

8.34

1.1

—

1.91

—

Other diseases of arteries and capillaries

174

1088

1.63

8.29

1.1

66.24

0.99

u/ml

—

Glaucoma

1063

7573

1.22

8.27

1.1

0.97

6.72

u/ml

0.99

116

Childhood allergy (age < 16)

512

3221

1.33

8.21

1.2

1.1

2.75

16.93

u/ml

—

Otitis media, unspecified

340

2249

1.42

8.20

1.2

1.1

3.83

4.04

u/ml

—

Retention of urine

555

3505

1.31

8.17

1.1

1.92

5.72

u/ml

—

Acute pharyngitis

389

2836

1.38

8.15

1.1

7.32

2.55

u/ml

—

Parkinson's disease, excluding more controls

210

1293

1.55

8.12

1.1

2.36

1.54

u/ml

—

Progressive vascular leukoencephalopathy

340

2.15

8.08

1.1

1.0

—

2.15

—

Unstable angina pectoris

611

3764

1.29

7.99

1.1

31.22

3.36

u/ml

—

In situ neoplasms

777

6270

1.25

7.99

1.1

33.54

4.49

u/ml

—

Open wound of head

1095

8804

1.21

7.99

1.1

22.25

10.13

u/ml

0.27

122

Syphilis

279

2.26

7.85

1.1

—

0.80

—

Syphilis

279

2.26

7.85

1.1

—

0.80

—

Viral warts

507

3899

1.32

7.83

1.1

31.45

8.67

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1288

8243

1.19

7.79

1.1

21.26

5.98

u/ml

0.52

137

Myopia

320

2300

1.41

7.77

1.1

88.62

2.80

u/ml

—

Cramp and spasm

114

651

1.80

7.75

1.1

—

0.89

—

Alcohol abuse, main dg

319

2290

1.41

7.75

1.1

1.44

11.04

u/ml

—

Appendectomy

1505

12370

1.17

7.71

1.1

10.32

10.20

u/ml

0.00

185

Other disorders of binocular vision

213

2.49

7.71

1.1

—

Fitting and adjustment of other devices

382

4631

0.74

7.71

1.1

1.26

5.22

u/ml

—

Vitamin deficiency, wide

112

640

1.80

7.59

1.1

6.80

0.94

u/ml

—

Vitamin deficiency

112

640

1.80

7.59

1.1

6.80

0.94

u/ml

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

7.24

7.57

1.3

1.1

—

Diseases of arteries, arterioles and capillaries

1226

7647

1.19

7.56

1.1

35.19

2.57

u/ml

0.75

116

Other infectious diseases

177

1142

1.58

7.43

1.1

55.40

1.39

u/ml

—

Invasive ventilation

154

963

1.63

7.43

1.1

—

1.36

u/ml

—

Nontoxic goitre/thyroid nodule

620

4923

1.27

7.43

1.1

1.88

1.67

u/ml

0.09

Varicose veins

1231

7869

1.19

7.43

1.1

1.12

7.57

u/ml

1.12

117

Postprocedural disorders of nervous system

186

1217

1.56

7.40

1.1

1.14

3.26

u/ml

—

Umbilical hernia

496

3830

1.31

7.39

1.1

2.56

18.86

u/ml

—

Inflammatory bowel disease, strict (require KELA)

509

3952

1.30

7.32

1.1

12.63

8.05

u/ml

—

Other disorders of nervous system

133

807

1.68

7.24

1.1

—

1.41

u/ml

—

Herpesviral [herpes simplex] infections

254

1776

1.45

7.23

1.1

—

1.63

—

ILD, hospital admissions 1, main diag only

227

1552

1.48

7.23

1.1

0.88

1.25

u/ml

—

Other viral diseases

711

5738

1.25

7.19

1.1

30.73

7.35

u/ml

0.38

Acute suppurative otitis media

704

5311

1.25

7.16

1.1

4.68

12.97

u/ml

0.67

Viral warts

237

1641

1.47

7.14

1.2

1.1

35.74

3.02

u/ml

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

576

4561

1.27

7.06

1.1

1.29

6.59

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs

165

2103

0.65

7.05

1.1

4.38

9.53

u/ml

—

Primary gonarthrosis, bilateral

945

6740

1.21

7.01

1.1

2.16

6.84

u/ml

0.73

118

Nontoxic multinodular goitre

401

3038

1.34

6.95

1.1

1.07

1.92

u/ml

—

Other disorders of breast

308

2254

1.39

6.78

1.1

1.98

3.09

u/ml

—

Extracorporeal dialysis

117

700

1.71

6.75

1.1

—

1.45

—

Fracture of skull and facial bones

429

3293

1.32

6.75

1.1

1.08

9.59

u/ml

—

Glaucoma suspect

682

5535

1.24

6.74

1.1

0.89

4.59

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

617

4959

1.25

6.66

1.1

0.97

9.22

u/ml

—

Otalgia

201

1373

1.49

6.57

1.1

2.40

21.94

u/ml

—

Other symptoms and signs involving the urinary system

188

1264

1.51

6.57

1.1

1.26

1.45

u/ml

—

Other infectious diseases

145

922

1.60

6.55

1.1

66.32

1.67

u/ml

—

Benign neoplasm of mouth and pharynx

212

1462

1.47

6.54

1.1

1.05

1.24

u/ml

—

Meralgia paraesthetica

391

1.95

6.51

1.1

1.0

—

0.82

—

Laparoscopic right hemicolectomy

111

662

1.71

6.51

1.0

1.1

—

2.32

—

Myocardial infarction, without ST-elevation

612

4487

1.25

6.45

1.1

1.12

9.69

u/ml

0.90

Anomalies of dental arch relationship, including avohilmo

513

3655

1.28

6.43

1.1

1.65

3.71

u/ml

0.82

Coxarthrosis, primary

1077

7747

1.18

6.39

1.1

0.90

7.17

u/ml

1.22

124

Other respiratory diseases principally affecting the interstitium

291

2131

1.38

6.33

1.1

0.88

1.19

u/ml

—

Other fall from one level to another

492

3879

1.28

6.32

1.1

0.88

14.41

u/ml

—

Heterophoria

207

1434

1.47

6.31

1.1

6.08

4.45

u/ml

—

Retinal detachments and breaks

631

5119

1.24

6.29

1.1

1.20

9.38

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

1368

10938

1.16

6.28

1.1

13.52

8.06

u/ml

0.22

154

Pyoderma gangrenosum

100

3.00

6.20

1.1

—

Conductive and sensorineural hearing loss

1595

9422

1.15

6.17

1.1

3.97

8.24

u/ml

0.53

143

All influenza (not pneumonia)

306

2270

1.36

6.16

1.1

41.70

12.17

u/ml

—

Traumatic subdural haemorrhage

186

1212

1.49

6.13

1.0

1.1

1.11

0.89

u/ml

—

Early onset COPD

383

2937

1.32

6.12

1.1

56.18

8.12

u/ml

—

Hydrocele

157

1032

1.54

6.09

1.1

—

16.30

—

Hypertrophy of breast in women and men

444

3479

1.29

6.06

1.1

1.40

2.54

u/ml

0.67

Other viral diseases, not elsewhere classified

439

3436

1.29

5.92

1.1

4.11

11.28

u/ml

—

Seropositive rheumatoid arthritis, strict definition

304

2270

1.36

5.92

1.1

34.05

1.82

u/ml

—

Hypermobility syndrome

147

965

1.56

5.90

1.1

—

0.84

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

413

1.87

5.88

1.1

—

1.00

—

ILD, hospital admissions

244

1760

1.40

5.87

1.1

0.88

1.22

u/ml

—

Cardiodefibrillation

560

4512

1.25

5.84

1.1

41.69

5.51

u/ml

—

Polyarthritis, unspecified

428

1.84

5.82

1.0

1.1

—

2.18

—

Gestational diabetes (for exclusion)

967

5723

1.18

5.65

1.1

1.91

5.62

u/ml

0.84

Car occupant injured in other and unspecified transport accidents

406

3178

1.29

5.61

1.1

2.50

10.50

u/ml

—

Causalgia

211

2.22

5.59

1.0

—

Interstitial lung disease

245

1785

1.39

5.58

1.1

0.88

1.22

u/ml

—

Interstitial lung disease endpoints

245

1785

1.39

5.58

1.1

0.88

1.22

u/ml

—

Other interstitial pulmonary diseases

245

1786

1.39

5.56

1.1

0.88

1.22

u/ml

—

LSIL lesion of the cervix uteri, vagina or vulva

347

2669

1.32

5.54

1.1

40.10

3.12

u/ml

—

Acute and transient psychotic disorders

239

1739

1.39

5.52

1.1

1.32

16.48

u/ml

—

Other spirochaetal diseases

615

5054

1.23

5.51

1.1

20.26

9.98

u/ml

—

Unspecified acute lower respiratory infection

281

2100

1.35

5.45

1.1

6.89

1.14

u/ml

—

Major coronary heart disease event excluding revascularizations

1064

6093

1.17

5.38

1.1

14.65

6.49

u/ml

0.28

Other predominantly sexually transmitted diseases, not elsewhere classified

404

3183

1.28

5.35

1.1

29.23

2.85

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

283

2127

1.34

5.29

1.1

0.92

1.63

u/ml

—

Ankylosing hyperostosis [Forestier]

115

2.62

5.22

1.0

—

u/ml

—

Calculus of kidney and ureter

504

4080

1.24

5.22

1.1

30.74

12.86

u/ml

—

Other nutritional anaemias

2.83

5.20

1.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS